|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2804878 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13702548.2 |
| Date of filing the European patent application | 2013-01-18 | |
| (97) | Date of publication of the European application | 2014-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation | 2018-12-10 |
| (86) | Number | PCT/US2013/022280 |
| Date | 2013-01-18 |
| (87) | Number | WO 2013/109974 |
| Date | 2013-07-25 |
| (30) | Number | Date | Country code |
| 201261588936 P | 2012-01-20 | US |
| (72) |
YOUD, Michele, US
TEDSTONE, Jennifer, US
LODIE, Tracey, US
CARTER, Karen, B., US
CONNORS, Timothy, D., US
PINCKNEY, Jason, Robert, US
MASTERJOHN, Elizabeth, US
CHU, Ruiyin, US
|
| (73) |
Genzyme Corporation,
50 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Anti-CXCR3 antikūnai |
| ANTI-CXCR3 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2020-12-16 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-01-18 |